0001493152-24-029911.txt : 20240801
0001493152-24-029911.hdr.sgml : 20240801
20240801160514
ACCESSION NUMBER: 0001493152-24-029911
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240801
FILED AS OF DATE: 20240801
DATE AS OF CHANGE: 20240801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schellens Johannes Henricus Matthias
CENTRAL INDEX KEY: 0002025872
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39717
FILM NUMBER: 241166526
MAIL ADDRESS:
STREET 1: LAAG NIEUWKOOP 10
CITY: KOCKENGEN
STATE: P7
ZIP: 3628 GC
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CENTRAL INDEX KEY: 0001335105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 202903526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 248 ROUTE 25A
STREET 2: NO. 2
CITY: EAST SETAUKET
STATE: NY
ZIP: 11733
BUSINESS PHONE: 310 203 2902
MAIL ADDRESS:
STREET 1: 248 ROUTE 25A
STREET 2: NO. 2
CITY: EAST SETAUKET
STATE: NY
ZIP: 11733
FORMER COMPANY:
FORMER CONFORMED NAME: SRKP 7 INC
DATE OF NAME CHANGE: 20050803
3
1
ownership.xml
X0206
3
2024-08-01
0
0001335105
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
0002025872
Schellens Johannes Henricus Matthias
680 EAST COLORADO BOULEVARD, SUITE 180
PASADENA
CA
91101
0
1
0
0
Chief Medical Officer
Options to Purchase Common Stock
2.39
2024-07-01
2029-07-01
Common Stock
15000
D
Effective July 1, 2024, under his Consulting Agreement with the Company, the Reporting Person was granted five-year options to purchase an aggregate of 15,000 shares of the Company's Common Stock vesting quarterly over a three year period commencing on the last day of each calendar quarter commencing September 30, 2024 until fully vested. On August 1, 2024, pursuant to the Consulting Agreement, the Reporting Person was appointed as the Company's Chief Medical Officer.
/s/ Jan H.M. Schellens
2024-08-01